Health Scan Startup Nets $700 Million in New Funding Round

Neko Health, the startup that blends body‑scanning with blood tests to spot health issues early, has closed a $700 million Series C funding round. The deal was led by Lightspeed Venture Partners and O. G. Venture Partners, building on a $260 million Series B that closed in January 2025.

How the Technology Works

• Body‑scanning visualises a patient’s internal structure.
• Blood tests identify markers of disease.
• Integration with Apple Health pulls in fitness data.

This triad gives clinicians a comprehensive snapshot of a patient’s health, enabling earlier intervention.

From Spotify to the Clinic

• Founders: Daniel Ek (Spotify co‑founder) and Hjalmar Nilsonne.
• Current presence: Clinics in the UK and Sweden.
• Expansion plans: First U.S. office slated for New York.

Neko has already processed over 100 000 scans and boasts a waitlist exceeding 350 000 people.

Notable Success Stories

• Calm founder Alex Tew shared on X that a scan uncovered a malignant mole on his back. He removed the spot and credited Neko for early detection.

The Competitive Landscape

• MidJourney (AI art company) is developing its own body scanner for future spa experiences, indicating growing interest in digital health diagnostics.

New Investors

The Series C round also welcomed:

• Atomico
• General Catalyst
• Lakestar
• Liberty City Ventures
• Positive Sum
• BDT & MSD

These investors underscore confidence in Neko’s disruptive model and its potential to reshape preventive healthcare.